Why will there never be a randomized trial for NTRK-rearranged tumors?

Nicolas Penel; Loïc Lebellec; Jean Yves Blay

doi:10.1016/j.annonc.2023.04.001

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2022

Distribution and Outcome of NTRK-Rearranged Mesenchymal Tumors (NMT): An Ambispective Cases Series

Armelle Dufresne, Daniel Pissaloux, Carine Ngo, Nicolas Penel, Axel Le Cesne, Nicolas Macagno, Hélène Vanacker, Myriam Jean‐Denis, Franck Tirode, Jean Yves Blay, Mehdi Brahmi

Article2023

Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors

Armelle Dufresne, Daniel Pissaloux, Carine Ngo, Nicolas Penel, Axel Le Cesne, Nicolas Macagno, Hélène Vanacker, Clémence Hénon, Myriam Jean‐Denis, K Rughoo, Franck Tirode, Jean Yves Blay, Mehdi Brahmi

Article2005

Will it be steroids for ever?

Peter J Barnes

Chapter in a book2010

Should there be a category: “grooming disorders?”

Lara Hoppe, Jonathan Ipser, Christine Löchner, Kevin G. F. Thomas, Dan Joseph Stein

Article2019

Will the Photobiomodulation Trial Be the One to Turn the Tide Against Alzheimer Disease

Michael R Hamblin